AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · IEX Real-Time Price · USD
16.03
-0.47 (-2.85%)
At close: Mar 28, 2024, 4:00 PM
15.46
-0.57 (-3.56%)
After-hours: Mar 28, 2024, 5:37 PM EDT

AVITA Medical Income Statement

Millions AUD. Fiscal year is Jan - Dec.
Year 20232022202120202019201820172016
Revenue
51.5737.6434.6218.1911.48.665.131.81
Revenue Growth (YoY)
37.03%8.73%90.31%59.62%31.54%68.74%184.18%-
Cost of Revenue
7.786.046.12.971.270.55-0.33-0.29
Gross Profit
43.7931.628.5115.2210.128.125.462.09
Selling, General & Admin
65.6345.2437.9648.7327.6514.285.35.26
Research & Development
20.8213.8615.679.1686.267.924.27
Other Operating Expenses
000001.421.130.68
Operating Expenses
86.4559.153.6357.935.6521.9614.3510.22
Operating Income
-42.66-27.51-25.12-42.68-25.53-13.84-8.89-8.12
Interest Expense / Income
1.140.020.030.030.030.0200
Other Expense / Income
-8.48-0.89-0.05-0.69-0.33-0.050.03-1.91
Pretax Income
-35.32-26.63-25.1-42.03-25.22-13.81-8.92-6.21
Income Tax
0.070.040.040-0.12-1.07-0.74-0.69
Net Income
-35.38-26.67-25.14-42.03-25.1-12.74-8.17-5.52
Shares Outstanding (Basic)
25252520169--
Shares Outstanding (Diluted)
25252520169--
Shares Change
1.32%0.30%22.84%26.31%72.24%---
EPS (Basic)
-1.40-1.07-1.01-2.07-1.56-1.37--
EPS (Diluted)
-1.40-1.07-1.01-2.07-1.56-1.37--
Free Cash Flow
-39.39-19.54-5.57-23.34-20.27-13.33-6.38-5.67
Free Cash Flow Per Share
-1.55-0.78-0.22-1.15-1.26-1.43--
Gross Margin
84.91%83.95%82.37%83.65%88.85%93.70%106.41%115.78%
Operating Margin
-82.71%-73.08%-72.56%-234.64%-224.03%-159.77%-173.16%-449.70%
Profit Margin
-68.61%-70.85%-72.63%-231.07%-220.29%-147.00%-159.19%-305.68%
Free Cash Flow Margin
-76.38%-51.92%-16.08%-128.30%-177.89%-153.82%-124.33%-313.87%
EBITDA
-32.79-25.35-24.41-41.03-24.93-13.68-8.92-6.21
EBITDA Margin
-63.59%-67.36%-70.53%-225.55%-218.75%-157.89%-173.69%-343.87%
Depreciation & Amortization
1.381.260.660.970.270.1100
EBIT
-34.17-26.61-25.07-41.99-25.2-13.79-8.92-6.21
EBIT Margin
-66.26%-70.71%-72.43%-230.87%-221.11%-159.16%-173.69%-343.87%
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).